Biopharmaceutical Manufacturing: Progress, Trends and Challenges (Cell Engineering, 11) by Ralf Pörtner
English | January 11, 2024 | ISBN: 3031456688 | 504 pages | MOBI | 15 Mb
This volume "Cell Engineerring 11 - Biopharmaceutical Manufacturing: Progress, Trends and Challenges" is a source of the latest innovative research and technical development in biomanufacturing systems. It is organised into 2 parts: 1) Manufacturing of recombinant therapeutic proteins (e.g. therapeutic antibodies, biosimilars/biogenerics) and 2) Manufacturing aspects of cell and gene therapy. Each with selected chapters on the following topics for both up- and downstream, such as: Advanced process strategies, especially continuous manufacturing, Advanced culture techniques, especially single-use systems, Process transfer, scale-up/scale-down models, Processing advances/Manufacturing productivity/efficiency, Model-assisted process understanding and development/Digital Twins, Process controls and analytics, Quality control, Quality by design, Facility design and full-scale commercial systems, manufacturing technology innovation.
The book comprises contributions of experts from academia and industry active in the field of cell culture development for the production of recombinant proteins, cell therapy and gene therapy, with consideration of Digital Twin´s and facility design. The knowledge and expertise of the authors cover disciplines like cell biology, engineering, biotechnology and biomedical sciences. Inevitably, some omissions will occur in the test, but the authors have sought to avoid duplications by extensive cross-referencing to chapters in other volumes of this series and elsewhere. We hope the volume provides a useful compendium of techniques for scientists in industrial and research laboratories active in this field.
Free Download
TakeFile Download Links Here
https://takefile.link/3psj4wvwvdtl/toany.rar.html
Fikper Download Links Here
https://fikper.com/iOV9mqAB0n/toany.rar.html
Links are Interchangeable - Single Extraction
Книги
